1. Home
  2. ANIP vs MSEX Comparison

ANIP vs MSEX Comparison

Compare ANIP & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • MSEX
  • Stock Information
  • Founded
  • ANIP 2001
  • MSEX 1897
  • Country
  • ANIP United States
  • MSEX United States
  • Employees
  • ANIP N/A
  • MSEX N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • MSEX Water Supply
  • Sector
  • ANIP Health Care
  • MSEX Utilities
  • Exchange
  • ANIP Nasdaq
  • MSEX Nasdaq
  • Market Cap
  • ANIP 1.3B
  • MSEX 1.2B
  • IPO Year
  • ANIP N/A
  • MSEX N/A
  • Fundamental
  • Price
  • ANIP $56.58
  • MSEX $66.98
  • Analyst Decision
  • ANIP Buy
  • MSEX Hold
  • Analyst Count
  • ANIP 6
  • MSEX 1
  • Target Price
  • ANIP $76.80
  • MSEX $61.00
  • AVG Volume (30 Days)
  • ANIP 278.1K
  • MSEX 86.1K
  • Earning Date
  • ANIP 11-08-2024
  • MSEX 10-31-2024
  • Dividend Yield
  • ANIP N/A
  • MSEX 2.03%
  • EPS Growth
  • ANIP N/A
  • MSEX 24.58
  • EPS
  • ANIP N/A
  • MSEX 2.30
  • Revenue
  • ANIP $555,456,000.00
  • MSEX $183,372,000.00
  • Revenue This Year
  • ANIP $23.69
  • MSEX $15.27
  • Revenue Next Year
  • ANIP $18.95
  • MSEX $6.33
  • P/E Ratio
  • ANIP N/A
  • MSEX $29.12
  • Revenue Growth
  • ANIP 23.60
  • MSEX 10.14
  • 52 Week Low
  • ANIP $48.20
  • MSEX $45.42
  • 52 Week High
  • ANIP $70.81
  • MSEX $73.47
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 42.32
  • MSEX 54.34
  • Support Level
  • ANIP $57.80
  • MSEX $65.30
  • Resistance Level
  • ANIP $63.23
  • MSEX $70.73
  • Average True Range (ATR)
  • ANIP 2.43
  • MSEX 2.17
  • MACD
  • ANIP -0.05
  • MSEX 0.07
  • Stochastic Oscillator
  • ANIP 13.41
  • MSEX 61.70

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm primarily operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

Share on Social Networks: